Stock Spotlight Archives - Page 232 of 392

FridayOct 02, 2020 2:27 pm

QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which thrives on its business-to-business (“B2B”) model to provide radical transparency for drug pricing and availability while taking advantage of telehealth-friendly insurer policy shifts under its business-to-consumer (“B2C”) model. During his presentation, Ajjarapu highlighted comprehensive capabilities of the platform, including the vitality of its Bonum Health Hub portal-led B2C operations, serving approximately 15 million patients through the medium of over 11,700 independent pharmacies in its subscription…

FridayOct 02, 2020 1:56 pm

QualityStocksNewsBreaks – Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Shares Road Map to Production, Promising Drill Program Results

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B),a Delaware corporation engaged in the acquisition, exploration and development of U.S. gold and silver properties, laid out its plan to become a profitable gold producer at the Aug. 6 OTCQB Virtual Investor Conference. Bullfrog was one of several companies hand selected to present to individual and institutional investors, advisors and analysts attending the event. A recent article discusses BFGC’s presentation and plans as the company’s CEO David Beling outlined the exciting potential of the Bullfrog Mining District of Nevada — the prolific location of BFGC properties — as well as promising…

FridayOct 02, 2020 1:43 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd., UltraPlay to Enhance Customer Engagement Through Loyalty, Gamification Programs and Cutting-Edge Tech

Mobius Interactive, a new online gaming operator with a variety of diverse offerings, has partnered with leading eSports and iGaming platform — UltraPlay — to attract a global network of high-net-worth gamers. The two companies are collaborating to enhance customer engagement through the use of loyalty and gamification programs. A recent article discussing this reads, “Currently, Mobius is partnering with UltraPlay to offer more than 34 unique games and sports betting available 24/7. Mobius’ sports betting product has a wide range of functionalities, mystery jackpots, cutting-edge tech and live and pre-match odds. In addition, the company’s live casino games are…

FridayOct 02, 2020 1:28 pm

QualityStocksNewsBreaks – Cybin Corp. CEO Eyes Opportunity in Psychedelics Space, Organic IP Expansion

Cybin Corp., a Canada-based, life-science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, recently announced the appointment of Doug Drysdale as the company’s chief executive officer. Well recognized in the pharmaceutical space, Drysdale brings more than three decades of experience and a recognition of psychedelics as a major breakthrough in treating mental health conditions. Amid the recent strong push for research and commercialization in the psychedelics sector, Drysdale seeks to pursue emerging opportunities and pave the road for the company’s rapid growth. “I am beyond excited to be joining the Cybin team,” Drysdale stated in a recent article of…

FridayOct 02, 2020 1:07 pm

QualityStocksNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Helomics CIO Discusses Convergence of AI, Data and Biology on DojoLIVE!

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, was featured in a recent article discussing the appearance of one of its executives, Helomics CIO Mark Collins, PhD, on DojoLIVE! (https://ibn.fm/Y9fBZ). POAI’s Helomics subsidiary applies AI to its rich data gathered from more than 150,000 tumors in an effort to personalize cancer therapies and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Collins addressed this powerful work and his longtime passion during the interview titled, “Can We Cure Cancer with Artificial Intelligence?” “The last 20 years of…

FridayOct 02, 2020 12:46 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. Setting the Stage for Success in Bringing Novel Products to Market

180 Life Sciences, a clinical-stage biotechnology company, is focused on research to solve one of the world’s most significant drivers of disease – inflammation. The company currently has three programs for the development of novel drugs in the areas of fibrosis and anti-TNF, inflammatory pain and ulcerative colitis in ex-smokers. A recent article discusses the company’s strategy to expedite the path to market. The piece reads, “180 Life Sciences has mitigated the risks of its drug development through multiple programs at various stages of development. The company is actively decreasing costs and expediting the time to market by using grant…

MondaySep 28, 2020 2:44 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) Deploys Traditional, Customized Techniques to Enable Successful ‘Golden Mile’ Harvest

Pac Roots (CSE: PACR), a Canadian cannabis company dedicated to producing premium-quality strains and products, is ramping up for a Fall 2020 harvest at its joint venture site with Rock Creek Farms, a 100-acre commercial hemp operation located in a productive area of British Columbia known as the “Golden Mile.” The partners leverage customary and new methods for quality production and expect to begin harvesting on October 15, 2020, with an initial projected biomass yield of 500,000 – 700,000 pounds. A recent article discussing this reads, “PacRoots and Rock Creek Farms have deployed several traditional and customized hemp farming techniques…

MondaySep 28, 2020 2:24 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: ATUMF) Making Strategic Moves Amid Surging Demand

GoldHaven Resources (CSE: GOH) (OTCQB: ATUMF), engaged in the business of acquiring and exploring mineral resource properties, was featured in a recent editorial. The piece, titled “One of ‘World’s Best-Performing Mainstream Assets,’ Gold Heading for Record Highs,” addresses several savvy mining resource companies that are making strategic moves amid global economic conditions and surging demand as investors turn to gold. The article reads, “Recognizing long-term trends, GoldHaven Resources is making significant moves in the gold mining industry. In the business of acquiring and exploring mineral resource properties, the Canada-based exploration company has so far identified four of its seven properties…

FridaySep 25, 2020 2:41 pm

QualityStocksNewsBreaks – 180 Life Sciences Corp. Advancing Lead Program, Plans Additional Clinical Trials

180 Life Sciences, a clinical-stage biotechnology company, is dedicated to producing solutions designed to battle inflammation when the body’s natural processes go awry. The company’s primary focus is to treat fibrosis and inflammation using anti-TNF therapy, designed to block the activity of TNF, a substance in the body that can cause inflammation and lead to immune-system diseases. The company is advancing on this front as discussed by a recent article that reads, “180 Life Sciences’ lead program is in phase 2b/3 clinical trials and expects to deliver its first results next year. Other clinical trials planned by the company are…

Site Search

Company Search

Category: Stock Spotlight